Gene-Editing Pioneer CRISPR Therapeutics Targets the $60 Billion CAR-T Market Jul 23, 2026 Life Science
Novo Nordisk Sues Eli Lilly Over ‘Deceptive’ GLP-1 Ads, Stock Impact Seen Limited Jul 21, 2026 Life Science
Oral Wegovy Dominates. Is Eli Lilly’s Trillion-Dollar Valuation Still Safe? Jul 17, 2026 Life Science
Pfizer Could Rewrite the GLP-1 Race — but Its 7% Yield Is Flashing a Warning Jul 10, 2026 Life Science
Vertex’s $10 Billion Crinetics Acquisition Lands Amid Record Stock High: Time to Buy? Jul 8, 2026 Life Science
Undervalued Pharma Dividend Plays: PFE Boasts 7.1% Forward Yield, BMY Delivers 4.3% Jul 7, 2026 Life Science
Triple-Digit Gains Haven’t Killed This Biotech’s Upside. Here’s What Comes Next Jul 5, 2026 Life Science
